Seminars in Nuclear Medicine
Volume 39, Issue 5 , Pages 348-353, September 2009

Multimodality Imaging: Beyond PET/CT and SPECT/CT

  • Simon R. Cherry, PhD

      Affiliations

    • Corresponding Author InformationAddress reprint requests to Simon R. Cherry, PhD, Department of Biomedical Engineering, Center for Molecular and Genomic Imaging, University of California–Davis, One Shields Ave, Davis, CA 95616

Department of Biomedical Engineering, Center for Molecular and Genomic Imaging, University of California–Davis, Davis, CA

Multimodality imaging with positron emission tomography/computed tomography (PET/CT) and single-photon emission computed tomography (SPECT)/CT has become commonplace in clinical practice and in preclinical and basic biomedical research. Do other combinations of imaging modalities have a similar potential to impact medical science and clinical medicine? Presently, the combination of PET or SPECT with magnetic resonance imaging (MRI) is an area of active research, while other, perhaps less obvious combinations, including CT/MRI and PET/optical also are being studied. In addition to the integration of the instrumentation, there are parallel developments in synthesizing imaging agents that can be viewed by multiple imaging modalities. Is the fusion of PET and SPECT with CT the ultimate answer in multimodality imaging, or is it just the first example of a more general trend toward harnessing the complementary nature of the different modalities on integrated imaging platforms?

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

PII: S0001-2998(09)00014-2

doi:10.1053/j.semnuclmed.2009.03.001

Seminars in Nuclear Medicine
Volume 39, Issue 5 , Pages 348-353, September 2009